Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Analgesia and Pain Management01:25

Analgesia and Pain Management

3.3K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
3.3K
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids01:21

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids

1.1K
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
1.1K
Nociception01:44

Nociception

28.4K
Nociception—the ability to feel pain—is essential for an organism’s survival and overall well-being. Noxious stimuli such as piercing pain from a sharp object, heat from an open flame, or contact with corrosive chemicals are first detected by sensory receptors, called nociceptors, located on nerve endings. Nociceptors express ion channels that convert noxious stimuli into electrical signals. When these signals reach the brain via sensory neurons, they are perceived as pain.
28.4K
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

7.2K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
7.2K
Pain01:20

Pain

2.1K
Pain serves as a critical warning signal that alerts the body to potential or actual harm. When mechanical pressure on the skin is intense, such as from a sharp pinch, the sensation transitions from touch to pain. Similarly, extreme temperatures, like a hot pot handle, convert the sensation of heat into pain. Pain can also result from overstimulation of other senses, such as blinding light, loud noise, or the intense heat from habañero peppers. This ability to sense pain is essential for...
2.1K
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

1.5K
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
1.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Intranasal dopamine: Anatomical pathways, biological mechanisms and neuromodulatory potential.

Neuroscience and biobehavioral reviews·2026
Same author

Multi-Omics and Single-Cell Dissection Reveals EXT1 as a Glycosylation-Linked Therapeutic Target in Cancer.

Oncology research·2026
Same author

Caregiver Mental Health and Sociodemographic Factors Associated with the Burden of Care in Taiwan Among Primary Caregivers of Patients with Major Depressive Disorder: A Cross-Sectional Study.

Neuropsychiatric disease and treatment·2026
Same author

Pharmacological effects of cardamonin in metabolic diseases: a review on preclinical studies.

Inflammopharmacology·2026
Same author

Baicalin Alleviates Chronic Restraint Stress-Induced Depression-like Behavior by Suppressing ROS/H<sub>2</sub>O<sub>2</sub> Generation via a BDNF-Associated Mechanism in Mice.

Antioxidants (Basel, Switzerland)·2026
Same author

Peripheral Analgesic Effect of a Novel Curcuminoid Derivative: Possible Involvement of Peripheral Opioid Receptor and ATP-Sensitive Potassium Ion Channel.

Pharmaceutics·2026

Related Experiment Video

Updated: May 3, 2026

Intracranial Pharmacotherapy and Pain Assays in Rodents
02:26

Intracranial Pharmacotherapy and Pain Assays in Rodents

Published on: April 9, 2019

5.0K

Targeting the cannabinoid system for pain relief?

Lih-Chu Chiou1, Sherry Shu-Jung Hu2, Yu-Cheng Ho3

  • 1Graduate Institute of Pharmacology, College of Medicine, National Taiwan University, Taipei, Taiwan; Department of Pharmacology, National Taiwan University, Taipei, Taiwan; Graduate Institute of Brain and Mind Sciences, College of Medicine, National Taiwan University, Taipei, Taiwan; Neurobiology and Cognitive Science Center, National Taiwan University, Taipei, Taiwan.

Acta Anaesthesiologica Taiwanica : Official Journal of the Taiwan Society of Anesthesiologists
|February 18, 2014
PubMed
Summary

Cannabinoids, like those in marijuana, relieve pain by activating receptors. New research reveals a novel pain relief pathway involving 2-AG in the brain, offering a promising strategy for managing pain.

Keywords:
CannabinoidsEndocannabinoids: anandamideNeuropeptides: orexinPainReceptors: metabotropic glutamate

More Related Videos

The Sciatic Nerve Cuffing Model of Neuropathic Pain in Mice
07:09

The Sciatic Nerve Cuffing Model of Neuropathic Pain in Mice

Published on: July 16, 2014

51.2K
Oromucosal as an Alternative Method for Administration of Cannabis Products in Rodents
03:43

Oromucosal as an Alternative Method for Administration of Cannabis Products in Rodents

Published on: August 22, 2025

769

Related Experiment Videos

Last Updated: May 3, 2026

Intracranial Pharmacotherapy and Pain Assays in Rodents
02:26

Intracranial Pharmacotherapy and Pain Assays in Rodents

Published on: April 9, 2019

5.0K
The Sciatic Nerve Cuffing Model of Neuropathic Pain in Mice
07:09

The Sciatic Nerve Cuffing Model of Neuropathic Pain in Mice

Published on: July 16, 2014

51.2K
Oromucosal as an Alternative Method for Administration of Cannabis Products in Rodents
03:43

Oromucosal as an Alternative Method for Administration of Cannabis Products in Rodents

Published on: August 22, 2025

769

Area of Science:

  • Neuroscience
  • Pharmacology
  • Pain Management

Background:

  • Cannabis constituents, cannabinoids, have been used for pain relief for centuries.
  • Their analgesic mechanisms involve activating cannabinoid receptors (CB1 and CB2).
  • Endocannabinoids like anandamide and 2-arachidonoylglycerol (2-AG) are key endogenous ligands.

Purpose of the Study:

  • To explore the analgesic mechanisms of cannabinoids and endocannabinoids.
  • To review novel pain relief strategies involving 2-AG.
  • To investigate the role of 2-AG in descending pain inhibition via the periaqueductal gray (PAG).

Main Methods:

  • Review of existing literature on cannabinoid pharmacology and endocannabinoid pathways.
  • Analysis of studies investigating 2-AG generation and function in the PAG.
  • Examination of signaling cascades, including Gq-protein-coupled receptor (GqPCR) activation, phospholipase C (PLC), and diacylglycerol lipase (DAGL).

Main Results:

  • Cannabinoid receptor activation is a primary analgesic mechanism.
  • Inhibiting endocannabinoid degradation enzymes (FAAH, MAGL) may offer pain relief without CNS side effects.
  • A novel analgesic pathway in the PAG involves GqPCR-PLC-DAGL-2-AG mediated retrograde disinhibition.
  • This pathway can be activated by mGluR5, M1/M3, and OX1 receptors, and modulated by various neurotransmitters and compounds like AM404.

Conclusions:

  • Understanding endocannabinoid pathways, particularly 2-AG signaling in the PAG, is crucial for developing novel analgesics.
  • Targeting the GqPCR-PLC-DAGL-2-AG cascade offers a promising strategy for pain management.
  • Further research into 2-AG's role in stress-induced analgesia may reveal additional therapeutic targets.